Document is current

Any future updates will be listed below

MARIPOSA demonstrates overall survival benefit from amivantamab–lazertinib

Crossref DOI link: https://doi.org/10.1038/s41571-025-01081-3

Published Online: 2025-09-23

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark